乳腺癌患者注射紫杉醇会影响月经吗?

2021-07-07 MedSci原创 MedSci原创

乳腺癌患者注射紫杉醇会影响月经吗?

《梅斯直播课:3天乳腺癌诊疗训练营》
06.25-年轻乳腺癌的治疗要点及生育管理
回答问题8:患者是第六次化疗,打了紫杉醇,月经推后了一星期了,请问,打了紫杉醇会影响月经吗?

 

欢迎点赞、评论、分享

评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 医鸣惊人

    认真学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-09 luwei00
  3. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=998052, encodeId=17df99805210, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Fri Jul 09 19:09:18 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376825, encodeId=719213e68255a, content=<a href='/topic/show?id=f8216055671' target=_blank style='color:#2F92EE;'>#月经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60556, encryptionId=f8216055671, topicName=月经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571268, encodeId=a73815e1268b1, content=<a href='/topic/show?id=f42823e48d7' target=_blank style='color:#2F92EE;'>#乳腺癌患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23748, encryptionId=f42823e48d7, topicName=乳腺癌患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37bc15724202, createdName=hanhaisha2013, createdTime=Fri Jul 09 08:46:46 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997312, encodeId=a78299e31273, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/7401feaddb86496e81b135d6c9603c84/6187b2991608473e950ff6a5c4ce999e.jpg, createdBy=ba1f5533734, createdName=机智哈, createdTime=Wed Jul 07 21:20:09 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 机智哈

    学习一下

    0

相关资讯

年轻乳腺癌的肿瘤特征是什么?复发风险和预后有何特点?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

BRCA1/2突变的年轻患者是否适宜保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

阳性且有转移的乳腺癌患者是只能注射靶向药治疗吗?

《梅斯直播课:3天乳腺癌诊疗训练营》 06.25-年轻乳腺癌的治疗要点及生育管理 回答问题6:阳性且有转移的治疗是只能一直打靶向药么?

年轻乳腺癌ofs+AI后仍未绝经,后续如何进行内分泌治疗?

年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

年轻乳腺癌应选择乳房切除术还是保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

拓展阅读

优化现有方案PFS延长约3个月,疾病控制率85%!《柳叶刀》子刊:或为晚期胃癌患者带来新选择

该研究展示出紫杉醇联合雷莫西尤单抗作为一线转换维持方案的疗效和安全性,这种转换维持策略或可作为一种潜在的治疗选择。

Lancet Oncol | 晚期胃癌治疗新突破:紫杉醇联合雷莫芦单抗,PFS 和 OS 双双获益(Ⅲ期ARMANI试验)

该研究显示紫杉醇联合雷莫芦单抗作为维持治疗或早期二线治疗,与继续使用基于奥沙利铂的双药化疗相比,可以显著改善患者的 PFS 和 OS,并且该治疗方案的安全性可控。

晚期胃癌治疗迎来重大突破!全球首款口服紫杉醇溶液在华落地

RMX3001作为全球第一款研发成功的口服剂型紫杉醇药物,其疗效已经在韩国III期临床研究DREAM研究中得到肯定,并在韩国获批用于胃癌二线治疗。

论文解读|Xiawei Wei/Xia Zhao教授团队揭示CSF-1R抑制剂联合紫杉醇可有效治疗卵巢癌

该研究探讨了CSF-1R抑制剂pexidartinib(PLX3397)与一线化疗药物紫杉醇联合治疗卵巢癌的抗肿瘤效果及其可能的作用机制。

CLIN CANCER RES | IPATunity130 III 期试验:帕他色替加紫杉醇治疗 PIK3CA/AKT1/PTEN 改变的局部晚期不可切除或转移性三阴性乳腺癌患者

该试验旨在验证帕他色替联合紫杉醇在PIK3CA/AKT1/PTEN突变晚期 TNBC 患者中的疗效和安全性,结果显示帕他色替与紫杉醇联合治疗并未显著改善 患者的 PFS 或 OS。

广西医科大学宁峙彭教授等团队合作IJS:发现他汀类药物联合紫杉醇改善乳腺癌预后新策略

体外实验和体内实验的结果表明,他汀类药物的使用与乳腺癌患者预后改善相关,并可能在促进“冷”肿瘤向“热”肿瘤转变方面发挥作用。